AssetMark Inc’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130K Buy
3,923
+335
+9% +$14.2K ﹤0.01% 1458
2025
Q4
$166K Sell
3,588
-963
-21% -$40.3K ﹤0.01% 1345
2025
Q3
$159K Buy
4,551
+352
+8% +$12.2K ﹤0.01% 1321
2025
Q2
$124K Sell
4,199
-310
-7% -$8.84K ﹤0.01% 1322
2025
Q1
$135K Sell
4,509
-180
-4% -$5.5K ﹤0.01% 1222
2024
Q4
$134K Sell
4,689
-202
-4% -$6.68K ﹤0.01% 1189
2024
Q3
$189K Sell
4,891
-524
-10% -$18.7K ﹤0.01% 1025
2024
Q2
$174K Buy
5,415
+514
+10% +$17.8K ﹤0.01% 1024
2024
Q1
$190K Sell
4,901
-544
-10% -$19K ﹤0.01% 950
2023
Q4
$168K Buy
5,445
+1,108
+26% +$27.8K ﹤0.01% 951
2023
Q3
$96.9K Buy
4,337
+281
+7% +$6.41K ﹤0.01% 993
2023
Q2
$87.2K Buy
4,056
+1,231
+44% +$27.9K ﹤0.01% 976
2023
Q1
$67.8K Buy
2,825
+885
+46% +$23.5K ﹤0.01% 967
2022
Q4
$45K Buy
1,940
+264
+16% +$5.32K ﹤0.01% 1067
2022
Q3
$27K Buy
1,676
+575
+52% +$10.1K ﹤0.01% 1074
2022
Q2
$20K Buy
1,101
+646
+142% +$10.9K ﹤0.01% 1114
2022
Q1
$9K Buy
+455
New +$8.6K ﹤0.01% 1201

Other funds holding COLL